With Julia Hilliker
On February 20, 2008, in Riegel v. Medtronic, Inc., the U.S. Supreme Court found that common law tort claims challenging the safety and effectiveness of devices that require premarket approval (PMA) under the Medical Device Amendments of 1976 (MDA) are preempted by federal law.